Patient Search

KaCrole Higgins was diagnosed with breast cancer in 2020. “In May 2020, I found a lump in my breast. I cried. By June, it was diagnosed as breast cancer, triple positive, stage 1A. While getting this cancer diagnosis was devastating, it also became an opportunity. Suddenly, the cancer gave me clarity. It gave me clarity about what was important, what was good in my life, what was toxic in my life, and what I needed to do.” Click below to read more of KaCrole’s story

https://momentum.vicc.org/2022/04/cancer-gave-me-clarity/

If Landon Ryan had been diagnosed with bilateral retinoblastoma 10, 20 or 30 years ago, she might not be here today with nearly perfect vision.Thanks to recent improvements in the treatment for this rare form of cancer that almost exclusively affects children under the age of 5, the diagnosis had the power to change Landon’s life when she was 11 months old, but not to take it — or her eyesight. Click below to learn more about Landon and her story.

https://momentum.vicc.org/2022/04/brighter-outlook/

Filter By:
Search by Keyword:

Displaying 311 - 320 of 415

A Phase 3, Multi-Center, Randomized, Double-blind Trial to Evaluate the
Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive
Hypertrophic Cardiomyopathy” and identified as CY 6032

Disease Sites: Not Available

Phase:

Investigator: Brinkley, Douglas

NCTID: NCT05767346

Protocol No: CRE-CHF0015

AMPLE-3: A Randomised Study Comparing Combined Indwelling Pleural Catheter (IPC) and Talc Pleurodesis with Video-Assisted Thoracoscopic Surgery (VATS) for the Management of Patients with Malignant Pleural Effusion

Lung

Disease Sites: Lung

Phase: N/A

Investigator: Shojaee, Samira

NCTID: NCT04322136

Protocol No: VICC-IDMDT23492

CY 6031 A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CK3773274 IN ADULTS WITH SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY AND LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION

Disease Sites: Not Available

Phase:

Investigator: Brinkley, Douglas

NCTID: NCT05186818

Protocol No: CRE-CHF0007

An Open Label, Expanded Access Protocol using 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy in Patients with Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Multiple Cancer Types

Disease Sites: Neuroblastoma (Pediatrics), Pediatric Solid Tumors

Phase: N/A

Investigator: Kitko, Carrie

NCTID: NCT01590680

Protocol No: VICCPED1249

The FARAPULSE ADVENT Trial

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID: NCT04612244

Protocol No: CRE-ARR0009

A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of VGA039 Following Intravenous or Subcutaneous Administration of Single Ascending Doses in Healthy Adults and
Adult Patients with von Willebrand Disease

Disease Sites: Not Available

Phase: I

Investigator: Wheeler, Allison

NCTID: NCT05776069

Protocol No: NCBH2304-VEGA

REDUCE Post Approval Study - GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO)

Disease Sites: Not Available

Phase:

Investigator: Piana, Robert

NCTID: NCT03821129

Protocol No: CRE-ARR0003

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma

Multiple Myeloma

Disease Sites: Multiple Myeloma

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID: NCT05346835

Protocol No: VICC-XDCTT24033

Preserving Fertility After Colorectal Cancer: The PREFACE Study

Multiple Cancer Types

Disease Sites: Colon, Rectal

Phase: N/A

Investigator: Holowatyj, Andreana

NCTID: NCT05239338

Protocol No: VICCGI2186

Open-Label Safety Study in Adults and Adolescents with Haemophilia A with and without FVIII Inhibitors Switching Directly from Emicizumab Prophylaxis to NNC0365-3769 (Mim8) Prophylaxis

Disease Sites: Not Available

Phase: III

Investigator: Walker, Shannon

NCTID: NCT05878938

Protocol No: NCBH2302-FRONTIER5